FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3116209969> ?p ?o ?g. }

• W3116209969 endingPage "297" @default.
• W3116209969 startingPage "287" @default.
• W3116209969 abstract "Malaria is one of the deadliest infectious diseases threatening half of the world population. With the deterioration of the parasiticidal effect of the current antimalarials, novel approaches such as screening of more specific inhibitors and targeted delivery of drugs have been under intensive research. Herein, we prepare hollow mesoporous ferrite nanoparticles (HMFNs) of 200 nm with ferromagnetic properties using a one-pot hydrothermal reaction. A magnetically targeted drug-delivery system coloaded with artemisinin in the inner magnetite shell and heparin on the outer mesoporous shell (HMFN@ART@HEP) is developed. Specific targeting of the magnetic nanoparticles to the parasite-infected erythrocytes is achieved by the attraction between the HMFNs and hemozoin (paramagnetic), a vital metabolite of plasmodium in the erythrocytic stage. With the hemozoin production reaching the maximum during the schizont period of the parasite, HMFN@ART@HEPs are adsorbed to the infected red blood cells (iRBCs), which not only interferes with the release of merozoites but also significantly enhances the inhibitory efficacy due to the increased local concentration of artemisinin. Subsequently, the heparin coated on the surface of the nanoparticles can efficiently interfere with the invasion of freshly released merozoites to new RBCs through the specific interaction between the parasite-derived ligands and heparin, which further increases the inhibitory effect on malaria. As a cluster of heparin, heparin-coated nanoparticles provide stronger blocking capability than free heparin, resulting from multivalent interactions with surface receptors on merozoite. Thus, we have developed a HMFN-based delivery system with considerable antimalarial efficacy, which is a promising platform for treatment against malaria." @default.
• W3116209969 created "2021-01-05" @default.
• W3116209969 creator A5001395097 @default.
• W3116209969 creator A5005005861 @default.
• W3116209969 creator A5034401025 @default.
• W3116209969 creator A5040523461 @default.
• W3116209969 creator A5052040807 @default.
• W3116209969 creator A5052046758 @default.
• W3116209969 creator A5064125549 @default.
• W3116209969 creator A5073789459 @default.
• W3116209969 creator A5075148400 @default.
• W3116209969 creator A5076762229 @default.
• W3116209969 creator A5088097195 @default.
• W3116209969 date "2020-12-24" @default.
• W3116209969 modified "2023-10-13" @default.
• W3116209969 title "Enhanced Antimalarial Efficacy Obtained by Targeted Delivery of Artemisinin in Heparin-Coated Magnetic Hollow Mesoporous Nanoparticles" @default.
• W3116209969 cites W1965003536 @default.
• W3116209969 cites W1969503178 @default.
• W3116209969 cites W1984364596 @default.
• W3116209969 cites W1986400970 @default.
• W3116209969 cites W1987250403 @default.
• W3116209969 cites W1997209259 @default.
• W3116209969 cites W1998019039 @default.
• W3116209969 cites W2006543510 @default.
• W3116209969 cites W2009600663 @default.
• W3116209969 cites W2024718588 @default.
• W3116209969 cites W2030427553 @default.
• W3116209969 cites W2038114362 @default.
• W3116209969 cites W2042016552 @default.
• W3116209969 cites W2052028492 @default.
• W3116209969 cites W2064405498 @default.
• W3116209969 cites W2073126015 @default.
• W3116209969 cites W2080816163 @default.
• W3116209969 cites W2084081008 @default.
• W3116209969 cites W2084123861 @default.
• W3116209969 cites W2088583682 @default.
• W3116209969 cites W2090155474 @default.
• W3116209969 cites W2090637305 @default.
• W3116209969 cites W2106780703 @default.
• W3116209969 cites W2118846793 @default.
• W3116209969 cites W2125198627 @default.
• W3116209969 cites W2127279078 @default.
• W3116209969 cites W2127745727 @default.
• W3116209969 cites W2128886090 @default.
• W3116209969 cites W2132140005 @default.
• W3116209969 cites W2148019354 @default.
• W3116209969 cites W2158550819 @default.
• W3116209969 cites W2165590938 @default.
• W3116209969 cites W2170223357 @default.
• W3116209969 cites W2171102256 @default.
• W3116209969 cites W2212792660 @default.
• W3116209969 cites W2258831804 @default.
• W3116209969 cites W2344949123 @default.
• W3116209969 cites W2346375768 @default.
• W3116209969 cites W2538382920 @default.
• W3116209969 cites W2579293200 @default.
• W3116209969 cites W2589856587 @default.
• W3116209969 cites W2593768764 @default.
• W3116209969 cites W2598705052 @default.
• W3116209969 cites W2603494472 @default.
• W3116209969 cites W2611363212 @default.
• W3116209969 cites W2744245504 @default.
• W3116209969 cites W2754212825 @default.
• W3116209969 cites W2756098300 @default.
• W3116209969 cites W2804632555 @default.
• W3116209969 cites W2924965307 @default.
• W3116209969 cites W2925128788 @default.
• W3116209969 cites W2949043934 @default.
• W3116209969 cites W2978987706 @default.
• W3116209969 cites W3081901971 @default.
• W3116209969 cites W4211051628 @default.
• W3116209969 cites W4211090760 @default.
• W3116209969 doi "https://doi.org/10.1021/acsami.0c20070" @default.
• W3116209969 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33356111" @default.
• W3116209969 hasPublicationYear "2020" @default.
• W3116209969 type Work @default.
• W3116209969 sameAs 3116209969 @default.
• W3116209969 citedByCount "13" @default.
• W3116209969 countsByYear W31162099692021 @default.
• W3116209969 countsByYear W31162099692022 @default.
• W3116209969 countsByYear W31162099692023 @default.
• W3116209969 crossrefType "journal-article" @default.
• W3116209969 hasAuthorship W3116209969A5001395097 @default.
• W3116209969 hasAuthorship W3116209969A5005005861 @default.
• W3116209969 hasAuthorship W3116209969A5034401025 @default.
• W3116209969 hasAuthorship W3116209969A5040523461 @default.
• W3116209969 hasAuthorship W3116209969A5052040807 @default.
• W3116209969 hasAuthorship W3116209969A5052046758 @default.
• W3116209969 hasAuthorship W3116209969A5064125549 @default.
• W3116209969 hasAuthorship W3116209969A5073789459 @default.
• W3116209969 hasAuthorship W3116209969A5075148400 @default.
• W3116209969 hasAuthorship W3116209969A5076762229 @default.
• W3116209969 hasAuthorship W3116209969A5088097195 @default.
• W3116209969 hasConcept C12554922 @default.
• W3116209969 hasConcept C155672457 @default.
• W3116209969 hasConcept C171250308 @default.
• W3116209969 hasConcept C185592680 @default.
• W3116209969 hasConcept C192562407 @default.

• next